TY - JOUR
T1 - Molecular origins of lung cancer
T2 - Prospects for personalized prevention and therapy
AU - Haura, Eric B.
AU - Camidge, D. Ross
AU - Reckamp, Karen
AU - Chiappori, Alberto
AU - Johnson, Faye
AU - Herbst, Roy
AU - Wong, Kwok
AU - Carbone, David
PY - 2010/6
Y1 - 2010/6
N2 - The first Meeting on "Molecular Origins of Lung Cancer - Prospects for Personalized Prevention and Therapy" was held from January 10 to 14, 2010 in San Diego, California. The purpose of the meeting was to discuss important basic, translational, and clinical work aimed at improving lung cancer prevention, detection, and treatment. Topics included drug design, target identification, early detection, cancer stem cells, microRNAs, genome wide approaches to determining risk and outcome, mouse models, and tumor microenvironment. The role of cancer advocates in supporting research was an important component of the meeting. Meeting presentations demonstrated that emerging technologies can molecularly dissect lung cancers that have important relevance for clinical utility. This includes molecular based strategies not only for treatment of established cancers but also individualized and molecularly-based strategies for cancer risk reduction and chemoprevention.
AB - The first Meeting on "Molecular Origins of Lung Cancer - Prospects for Personalized Prevention and Therapy" was held from January 10 to 14, 2010 in San Diego, California. The purpose of the meeting was to discuss important basic, translational, and clinical work aimed at improving lung cancer prevention, detection, and treatment. Topics included drug design, target identification, early detection, cancer stem cells, microRNAs, genome wide approaches to determining risk and outcome, mouse models, and tumor microenvironment. The role of cancer advocates in supporting research was an important component of the meeting. Meeting presentations demonstrated that emerging technologies can molecularly dissect lung cancers that have important relevance for clinical utility. This includes molecular based strategies not only for treatment of established cancers but also individualized and molecularly-based strategies for cancer risk reduction and chemoprevention.
UR - http://www.scopus.com/inward/record.url?scp=77953108643&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77953108643&partnerID=8YFLogxK
U2 - 10.1097/JTO.0b013e3181e2f682
DO - 10.1097/JTO.0b013e3181e2f682
M3 - Article
C2 - 20502275
AN - SCOPUS:77953108643
SN - 1556-0864
VL - 5
SP - S207-S213
JO - Journal of Thoracic Oncology
JF - Journal of Thoracic Oncology
IS - 6 SUPPL. 3
ER -